Mar 19, 2026
Dr. Monty Pal and Dr. Vamsi Velcheti discuss the evolving treatment landscape in EGFR-mutated non-small cell lung cancer, including landmark trials like FLAURA2, novel drug therapies, and the growing importance of ctDNA and MRD testing.
TRANSCRIPT
Dr. Monty Pal: Hello, and welcome to the ASCO Daily News Podcast. I'm...
May 26, 2022
Guest host Dr. Neeraj Agarwal, of the University of Utah Huntsman Cancer Institute and the ASCO Daily News editor-in-chief, discusses key therapeutic advances in mRCC and mUC, as well as new research that proposes periodic scans to monitor patients with mCSPC for disease progression, with Dr. Jeanny-Aragon-Ching of the...
Mar 24, 2022
Host Dr. John Sweetenham, associate director of Clinical Affairs at the UT Southwestern Harold C. Simmons Comprehensive Cancer Center, and Dr. Zeina Nahleh, breast cancer medical oncologist and regional chair of the Cleveland Clinic Florida Cancer Institute, discuss the new ASCO Expert Panel report on the use of...
Dec 19, 2019
ASCO Daily News: Welcome to the ASCO Daily News Podcast. I'm Lauren Davis, and joining me today is Dr. Megan Cruz, a medical oncologist at the Cleveland Clinic who treats patients with breast cancer.
ASCO Daily News: Today we're talking about a new therapeutic option for patients with metastatic breast cancer who carry...
Dec 5, 2019
ASCO Daily News: Welcome to the ASCO Daily News podcast. I'm Lauren Davis. And joining me today is ASCO's past president, Dr. Julie Vose, world renowned expert in the treatment of hematologic malignancies. Dr. Vose is the chair of the Hematologic Malignancies Exam Subcommittee, which determine the blueprint and testing...